Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 33.3%, free cash flow grew 12.7% and total debt fell 12.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

16.42 0.33 +2.05%
Market cap
$10.9B
P/E
0.0×
Fwd P/E
25.5×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
1.29 1.19 0.81 1.02
P/FCF ratio
16.25 15.76 12.07 14.72
P/Operating CF
41.02 51.08 90.25 37.57
P/B ratio
1.53 1.40 0.95 1.19
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
1.84 1.74 1.35 1.54
EV/EBITDA
17.75 65.97 68.22 80.81
EV/Operating CF
18.80 18.24 15.41 16.89
EV/FCF
23.14 22.99 20.13 22.18
Quick Ratio
0.88 1.04 1.01 1.05
Current Ratio
1.49 1.78 1.76 1.78
Net Debt/EBITDA
(6.65) 15.46 17.14 14.80
Debt/Assets
33.04% 33.46% 32.72% 31.89%
Debt/Equity
0.69 0.71 0.68 0.66
Asset Turnover
0.54 0.55 0.55 0.54
Operating CF/Net income
(0.29) 2.91 1.36 4.68
Capex/Depreciation
(0.33) (0.34) (0.31) (0.35)
Interest Coverage
(14.68) 3.16 2.32 3.09
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
24.04% 23.59% 25.37% 24.53%
Intangible Assets out of Total Assets
0.71 0.69 0.69 0.69
Share Based Compensation of Revenue
0.44% 0.68% 0.54% 0.91%
Graham Net Nets
(0.45) (0.48) (0.69) (0.52)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(0.96%) (6.81%) (10.33%) (8.48%)
Free Cash Flow Yield
6.15% 6.35% 8.29% 6.79%
Revenue per Share
2.38 2.44 2.34 2.50
Operating CF per Share
0.30 0.22 0.09 0.26
Capex per Share
(0.05) (0.05) (0.05) (0.06)
Free Cash Flow per Share
0.25 0.17 0.04 0.21
Cash per Share
0.37 0.54 0.41 0.45
Shareholders Equity per Share
8.17 8.18 8.27 8.33
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
8.17 8.18 8.27 8.33
Free Cash Flow
171.70 117.20 25.20 140.60
Working Capital
740.70 1,072.30 1,037.00 1,080.20
Capital Expenditures
(35.70) (35.50) (33.50) (37.60)
Net Current Asset Value
(3,848.50) (3,778.50) (3,670.00) (3,503.50)
EV/EBIT
45.63 0.00 0.00 0.00
Capex to Sales
0.02 0.02 0.02 0.02
Price to Operating Income
32.04 0.00 0.00 0.00
Other line items
Average Receivables
1,082.70 1,054.55 1,100.55 1,144.15
Average Payables
682.55 702.25 707.80 726.00
Average Inventory
787.55 774.85 780.20 804.25
Average Assets
12,258.25 11,954.60 11,994.70 12,186.40
Average Common Equity
5,561.70 5,760.85 5,843.45 5,958.05

Fold the line items

Columns are period end dates